{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:43:21Z","timestamp":1789181001006,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-026-07918-y","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:18:23Z","timestamp":1784787503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Guideline-directed Low-density Lipoprotein Cholesterol Management After Acute Coronary Syndrome in Patients With Mental Illness: a Population-based Study"],"prefix":"10.1007","author":[{"given":"Yuval","family":"Avidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Kobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matan","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barak","family":"Zafrir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"38","key":"7918_CR1","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191.","journal-title":"Eur Heart J"},{"issue":"34","key":"7918_CR2","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","journal-title":"Eur Heart J"},{"issue":"36","key":"7918_CR3","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177.","journal-title":"Eur Heart J"},{"issue":"6","key":"7918_CR4","doi-asserted-by":"publisher","first-page":"e021444","DOI":"10.1161\/JAHA.121.021444","volume":"11","author":"RC Rossom","year":"2022","unstructured":"Rossom RC, Hooker SA, O\u2019Connor PJ, Crain AL, Sperl-Hillen JM. Cardiovascular Risk for Patients With and Without Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder. J Am Heart Assoc. 2022;11(6):e021444. https:\/\/doi.org\/10.1161\/JAHA.121.021444.","journal-title":"J Am Heart Assoc"},{"key":"7918_CR5","doi-asserted-by":"publisher","DOI":"10.15420\/icr.2022.31","author":"B Tam To","year":"2023","unstructured":"Tam To B, Roy R, Melikian N, Gaughran FP, O\u2019Gallagher K. Coronary artery disease in patients with severe mental illness. Interv Cardiol Rev Resour. 2023. https:\/\/doi.org\/10.15420\/icr.2022.31.","journal-title":"Interv Cardiol Rev Resour"},{"issue":"6","key":"7918_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","volume":"24","author":"M De Hert","year":"2009","unstructured":"De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, M\u00f6ller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009;24(6):412\u201324. https:\/\/doi.org\/10.1016\/j.eurpsy.2009.01.005.","journal-title":"Eur Psychiatry"},{"issue":"6","key":"7918_CR7","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/S2468-2667(18)30077-X","volume":"3","author":"D Krupchanka","year":"2018","unstructured":"Krupchanka D, Mlad\u00e1 K, Winkler P, Khazaal Y, Albanese E. Mortality in people with mental disorders in the Czech Republic: a nationwide, register-based cohort study. Lancet Public Health. 2018;3(6):e289\u201395. https:\/\/doi.org\/10.1016\/S2468-2667(18)30077-X.","journal-title":"Lancet Public Health"},{"issue":"1","key":"7918_CR8","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2020.27","volume":"63","author":"U John","year":"2020","unstructured":"John U, Rumpf HJ, Hanke M, Meyer C. Mental disorders and total mortality after 20 years in an adult general population sample. Eur Psychiatry. 2020;63(1):e30. https:\/\/doi.org\/10.1192\/j.eurpsy.2020.27.","journal-title":"Eur Psychiatry"},{"issue":"17","key":"7918_CR9","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1093\/eurheartj\/ehy913","volume":"41","author":"V Vaccarino","year":"2020","unstructured":"Vaccarino V, Badimon L, Bremner JD, Cenko E, Cubedo J, Dorobantu M, et al. Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. Eur Heart J. 2020;41(17):1687\u201396. https:\/\/doi.org\/10.1093\/eurheartj\/ehy913.","journal-title":"Eur Heart J"},{"issue":"5","key":"7918_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-019-0724-5","volume":"21","author":"T Dar","year":"2019","unstructured":"Dar T, Radfar A, Abohashem S, Pitman RK, Tawakol A, Osborne MT. Psychosocial stress and cardiovascular disease. Curr Treat Options Cardiovasc Med. 2019;21(5):23. https:\/\/doi.org\/10.1007\/s11936-019-0724-5.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"11","key":"7918_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00392-019-01488-w","volume":"108","author":"C Albus","year":"2019","unstructured":"Albus C, Waller C, Fritzsche K, Gunold H, Haass M, Hamann B, et al. Significance of psychosocial factors in cardiology: update 2018. Clin Res Cardiol. 2019;108(11):1175\u201396. https:\/\/doi.org\/10.1007\/s00392-019-01488-w.","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"7918_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pharmthera.2012.04.003","volume":"135","author":"JYT Leung","year":"2012","unstructured":"Leung JYT, Barr AM, Procyshyn RM, Honer WG, Pang CCY. Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system. Pharmacol Ther. 2012;135(2):113\u201322. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.04.003.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"7918_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S2215-0366(14)00023-6","volume":"1","author":"C Henderson","year":"2014","unstructured":"Henderson C, Noblett J, Parke H, Clement S, Caffrey A, Gale-Grant O, et al. Mental health-related stigma in health care and mental health-care settings. Lancet Psychiatry. 2014;1(6):467\u201382. https:\/\/doi.org\/10.1016\/S2215-0366(14)00023-6.","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"7918_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1192\/bjp.bp.107.045732","volume":"194","author":"AJ Mitchell","year":"2009","unstructured":"Mitchell AJ, Malone D, Doebbeling CC. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry. 2009;194(6):491\u20139. https:\/\/doi.org\/10.1192\/bjp.bp.107.045732.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"7918_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019;41(1):111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"key":"7918_CR16","doi-asserted-by":"publisher","unstructured":"Avidan Y, Kassem S. Preoperative Thyroid Assessment in Pacemaker Recipients: Are We Falling Short? Am J Cardiol. 2025;256:66\u201371. https:\/\/doi.org\/10.1016\/j.amjcard.2025.07.024.","DOI":"10.1016\/j.amjcard.2025.07.024."},{"key":"7918_CR17","doi-asserted-by":"publisher","unstructured":"Avidan Y, Danon A, Hadar D, Aker A, Yahav A, Caspi O,Kassem S. Favorable outcomes of SGLT2 inhibitor use in pacemaker recipients: a population-based study. Cardiovasc Diabetol. 2025;24(1):433. https:\/\/doi.org\/10.1186\/s12933-025-02992-2.","DOI":"10.1186\/s12933-025-02992-2."},{"issue":"13","key":"7918_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/eurheartj\/ehad870","volume":"45","author":"RA Byrne","year":"2024","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. Correction to: 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2024;45(13):1145\u20131145. https:\/\/doi.org\/10.1093\/eurheartj\/ehad870.","journal-title":"Eur Heart J."},{"issue":"39","key":"7918_CR19","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37(39):2999\u20133058. https:\/\/doi.org\/10.1093\/eurheartj\/ehw272.","journal-title":"Eur Heart J"},{"issue":"25","key":"7918_CR20","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000625","volume":"139","author":"SM Grundy","year":"2018","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;139(25):e1082. https:\/\/doi.org\/10.1161\/CIR.0000000000000625.","journal-title":"Circulation"},{"issue":"11","key":"7918_CR21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","volume":"28","author":"KK Ray","year":"2021","unstructured":"Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, et al. EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study. Eur J Prev Cardiol. 2021;28(11):1279\u201389. https:\/\/doi.org\/10.1093\/eurjpc\/zwaa047.","journal-title":"Eur J Prev Cardiol"},{"issue":"9753","key":"7918_CR22","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration","year":"2010","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. The Lancet. 2010;376(9753):1670\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(10)61350-5.","journal-title":"The Lancet"},{"issue":"9976","key":"7918_CR23","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","volume":"385","author":"CT Trialists","year":"2015","unstructured":"Trialists CT. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. The Lancet. 2015;385(9976):1397\u2013405. https:\/\/doi.org\/10.1016\/S0140-6736(14)61368-4.","journal-title":"The Lancet"},{"issue":"42","key":"7918_CR24","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","volume":"46","author":"F Mach","year":"2025","unstructured":"Mach F, Koskinas KC, Roeters van Lennep JE, Tokg\u00f6zo\u011flu L, Badimon L, Baigent C, et al. Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2025;46(42):4359\u201378. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf190.","journal-title":"Eur Heart J"},{"issue":"7","key":"7918_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5551\/jat.48603","volume":"26","author":"H Daida","year":"2019","unstructured":"Daida H, Dohi T, Fukushima Y, Ohmura H, Miyauchi K. The goal of achieving atherosclerotic plaque regression with lipid-lowering therapy: insights from IVUS trials. J Atheroscler Thromb. 2019;26(7):592\u2013600. https:\/\/doi.org\/10.5551\/jat.48603.","journal-title":"J Atheroscler Thromb"},{"issue":"25","key":"7918_CR26","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387\u201397. https:\/\/doi.org\/10.1056\/NEJMoa1410489.","journal-title":"N Engl J Med"},{"issue":"18","key":"7918_CR27","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.2022.5218","volume":"327","author":"L R\u00e4ber","year":"2022","unstructured":"R\u00e4ber L, Ueki Y, Otsuka T, Losdat S, H\u00e4ner JD, Lonborg J, et al. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction. JAMA. 2022;327(18):1771. https:\/\/doi.org\/10.1001\/jama.2022.5218.","journal-title":"JAMA"},{"key":"7918_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1549935","author":"F Noack","year":"2025","unstructured":"Noack F, Eckrich K, V\u00f6ller H, Schwaab B, Heinze V, Bongarth C, et al. Lipid-lowering therapy (LLT) in 1,100 cardiac rehabilitation patients with coronary heart disease: the LLT-R(ehabilitation) registry. Front Cardiovasc Med. 2025. https:\/\/doi.org\/10.3389\/fcvm.2025.1549935.","journal-title":"Front Cardiovasc Med"},{"key":"7918_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","volume":"285","author":"G De Backer","year":"2019","unstructured":"De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner \u017d, Ryd\u00e9n L, et al. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis. 2019;285:135\u201346. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.03.014.","journal-title":"Atherosclerosis"},{"issue":"2","key":"7918_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/ehjcvp\/pvz079","volume":"6","author":"H Drexel","year":"2020","unstructured":"Drexel H, Coats AJS, Spoletini I, Bilato C, Mollace V, Perrone Filardi P, et al. An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: barriers to be overcome. Eur Heart J Cardiovasc Pharmacother. 2020;6(2):115\u201321. https:\/\/doi.org\/10.1093\/ehjcvp\/pvz079.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"3","key":"7918_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jacl.2019.05.006","volume":"13","author":"J Hartz","year":"2019","unstructured":"Hartz J, Hegele RA, Wilson DP. Low LDL cholesterol\u2014friend or foe? J Clin Lipidol. 2019;13(3):367\u201373. https:\/\/doi.org\/10.1016\/j.jacl.2019.05.006.","journal-title":"J Clin Lipidol"},{"key":"7918_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109737","volume":"96","author":"M Shao","year":"2020","unstructured":"Shao M, Tian H, Wang L, Jiang D, Ji F, Zhuo C. Mortality risk following acute coronary syndrome among patients with schizophrenia: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96:109737. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109737.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7918_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijcard.2017.01.067","volume":"236","author":"MB Protty","year":"2017","unstructured":"Protty MB, Lacey A, Smith D, Hannoodee S, Freeman P. Increased morbidity, mortality and length of in-hospital stay for patients with acute coronary syndrome with pre-morbid psychiatric diagnoses. Int J Cardiol. 2017;236:5\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.067.","journal-title":"Int J Cardiol"},{"issue":"7","key":"7918_CR34","doi-asserted-by":"publisher","first-page":"e034135","DOI":"10.1136\/bmjopen-2019-034135","volume":"10","author":"J Li","year":"2020","unstructured":"Li J, Ji F, Song J, Gao X, Jiang D, Chen G, et al. Anxiety and clinical outcomes of patients with acute coronary syndrome: a meta-analysis. BMJ Open. 2020;10(7):e034135. https:\/\/doi.org\/10.1136\/bmjopen-2019-034135.","journal-title":"BMJ Open"},{"issue":"1","key":"7918_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-01937-2","volume":"19","author":"K Fleetwood","year":"2021","unstructured":"Fleetwood K, Wild SH, Smith DJ, Mercer SW, Licence K, Sudlow CLM, et al. Severe mental illness and mortality and coronary revascularisation following a myocardial infarction: a retrospective cohort study. BMC Med. 2021;19(1):67. https:\/\/doi.org\/10.1186\/s12916-021-01937-2.","journal-title":"BMC Med"},{"issue":"6","key":"7918_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.amjcard.2016.06.051","volume":"118","author":"J Schulman-Marcus","year":"2016","unstructured":"Schulman-Marcus J, Shah T, Swaminathan RV, Feldman DN, Wong SC, Singh HS, et al. Comparison of recent trends in patients with and without major depression and acute ST-elevation myocardial infarction. Am J Cardiol. 2016;118(6):779\u201384. https:\/\/doi.org\/10.1016\/j.amjcard.2016.06.051.","journal-title":"Am J Cardiol"},{"issue":"9","key":"7918_CR37","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.amjcard.2016.02.006","volume":"117","author":"J Schulman-Marcus","year":"2016","unstructured":"Schulman-Marcus J, Goyal P, Swaminathan RV, Feldman DN, Wong SC, Singh HS, et al. Comparison of trends in incidence, revascularization, and in-hospital mortality in ST-elevation myocardial infarction in patients with versus without severe mental illness. Am J Cardiol. 2016;117(9):1405\u201310. https:\/\/doi.org\/10.1016\/j.amjcard.2016.02.006.","journal-title":"Am J Cardiol"},{"issue":"12","key":"7918_CR38","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.2742","volume":"75","author":"P Kugathasan","year":"2018","unstructured":"Kugathasan P, Horsdal HT, Aagaard J, Jensen SE, Laursen TM, Nielsen RE. Association of secondary preventive cardiovascular treatment after myocardial infarction with mortality among patients with schizophrenia. JAMA Psychiat. 2018;75(12):1234. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.2742.","journal-title":"JAMA Psychiat"},{"issue":"16","key":"7918_CR39","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","volume":"382","author":"KK Ray","year":"2020","unstructured":"Ray KK, Wright RS, Kallend D, Koenig W, Leiter LA, Raal FJ, et al. Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. N Engl J Med. 2020;382(16):1507\u201319. https:\/\/doi.org\/10.1056\/NEJMoa1912387.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07918-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:18:24Z","timestamp":1784787504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07918-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":39,"alternative-id":["7918"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07918-y","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for this study was obtained from the Carmel Medical Center Ethics Committee (0135\u201325-CMC).","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived due to the retrospective nature of this study.","order":2,"name":"Ethics","label":"Informed Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","label":"Conflict of interests\/Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}